Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Notified -
Globe Newswire9-12-2025, 20:00
American Battery Solutions, Inc. Confirms Exceptional Reliability of TeraStor™ BESS System with Third-party Analysis 24-05-2023, 18:46